UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial

The lancet oncology, 2022-01, Vol.23 (1), p.91-103

2022

Volltextzugriff (PDF)

Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease

The New England journal of medicine, 2012-07, Vol.367 (2), p.135-145

2012

Volltextzugriff (PDF)

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

PloS one, 2016-06, Vol.11 (6), p.e0158156

2016

Volltextzugriff (PDF)

Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity

Nature communications, 2017-12, Vol.8 (1), p.2125-14, Article 2125

2017

Volltextzugriff (PDF)

Variable selection methods for predicting clinical outcomes following allogeneic hematopoietic cell transplantation

Scientific reports, 2021-02, Vol.11 (1), p.3230-3230, Article 3230

2021

Volltextzugriff (PDF)

Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study

Journal of clinical oncology, 2021-06, Vol.39 (17), p.1878-1887

2021

Volltextzugriff (PDF)

Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies

Annals of hematology, 2021-07, Vol.100 (7), p.1863-1870

2021

Volltextzugriff (PDF)

Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis

Blood, 2017-02, Vol.129 (7), p.906-916

2017

Volltextzugriff (PDF)

Post-transplant lymphoproliferative disorder after lung transplantation: A review of 35 cases

The Journal of heart and lung transplantation, 2012-03, Vol.31 (3), p.296-304

2012

Volltextzugriff (PDF)

TGM4: an immunogenic prostate-restricted antigen

Journal for immunotherapy of cancer, 2021-06, Vol.9 (6), p.e001649

2021

Volltextzugriff (PDF)

Posttransplant Lymphoproliferative Disorder Following Kidney Transplant

American journal of kidney diseases, 2010-01, Vol.55 (1), p.168-180

2010

Volltextzugriff (PDF)

Arginine uptake is attenuated, through post-translational regulation of cationic amino acid transporter-1, in hyperlipidemic rats

Atherosclerosis, 2007-10, Vol.194 (2), p.357-363

2007

Volltextzugriff (PDF)

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Journal of clinical oncology, 2017-12, Vol.35 (36), p.4003-4011

2017

Volltextzugriff (PDF)

Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials

Biology of blood and marrow transplantation, 2018-06, Vol.24 (6), p.1274-1280

2018

Volltextzugriff (PDF)

Iatrogenic Infertility After Curative Stem Cell Transplantation in Patients With Sickle Cell Disease

Annals of internal medicine, 2018-06, Vol.168 (12), p.881

2018

Volltextzugriff (PDF)

Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation

Journal of clinical oncology, 2021-07, Vol.39 (21), p.2397-2409

2021

Volltextzugriff (PDF)

Chimeric antigen receptor T cells for treatment of transformed Waldenström macroglobulinemia

Leukemia & lymphoma, 2020-01, Vol.61 (2), p.465-468

2020

Volltextzugriff (PDF)

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)

The Lancet. Haematology, 2019-03, Vol.6 (3), p.e132-e143

2019

Volltextzugriff (PDF)

High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia

Blood, 2024-06, Vol.143 (26), p.2804-2807

2024

Volltextzugriff (PDF)

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

Journal of clinical oncology, 2016-06, Vol.34 (16), p.1864-1871

2016

Volltextzugriff (PDF)

High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning

Journal of clinical oncology, 2015-07, Vol.33 (21), p.2392-2398

2015

Volltextzugriff (PDF)

Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol

Blood advances, 2024-06, Vol.8 (12), p.3001-3012

2024

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

KollektionEbook Central Perpetual and DDA

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Humans
(40)
Female
(38)
Life Sciences & Biomedicine
(38)
Middle Aged
(34)
Aged
(32)
Adult
(31)
Hematology
(23)
Young Adult
(19)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(18)
Transplantation
(18)
Treatment Outcome
(16)
Hematopoietic Stem Cell Transplantation - Methods
(15)
Adolescent
(12)
Graft Vs Host Disease - Prevention & Control
(12)
Transplantation, Homologous
(11)
Retrospective Studies
(10)
Graft Vs Host Disease - Etiology
(9)
Immunology
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial

Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity

Variable selection methods for predicting clinical outcomes following allogeneic hematopoietic cell transplantation

Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study

Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies

Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis

Post-transplant lymphoproliferative disorder after lung transplantation: A review of 35 cases

TGM4: an immunogenic prostate-restricted antigen

Posttransplant Lymphoproliferative Disorder Following Kidney Transplant

Arginine uptake is attenuated, through post-translational regulation of cationic amino acid transporter-1, in hyperlipidemic rats

HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials

Iatrogenic Infertility After Curative Stem Cell Transplantation in Patients With Sickle Cell Disease

Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation

Chimeric antigen receptor T cells for treatment of transformed Waldenström macroglobulinemia

High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD

High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning

Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma

Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol

Aktive Filter

Suchergebnisse filtern